Anemia hemolítica autoinmune en Chile: un análisis retrospectivo de 43 pacientes



Document title: Anemia hemolítica autoinmune en Chile: un análisis retrospectivo de 43 pacientes
Journal: Revista médica de Chile
Database: PERIÓDICA
System number: 000431085
ISSN: 0034-9887
Authors: 1
1
1
1
2
Institutions: 1Hospital del Salvador, Sección de Hematología, Santiago de Chile. Chile
2Universidad de Chile, Facultad de Medicina, Santiago de Chile. Chile
Year:
Season: Jul
Volumen: 147
Number: 7
Pages: 836-841
Country: Chile
Language: Español
Document type: Artículo
Approach: Analítico, descriptivo
English abstract Autoimmune hemolytic anemia (AIHA) is an uncommon disease. In its presentation, it can be severe and even lethal. There is only one clinical report concerning this pathology in Chile. Objective: To describe the clinical characteristics and evolution of adult AIHA inpatients. Materials and Methods: Retrospective review of clinical records of adult AIHA inpatients between January 2010 and June 2018 was done. Demographic, clinical, laboratory and therapeutic information was analyzed. A descriptive, analytical and survival analysis was performed. Results: Forty-three adult patients diagnosed with AHIA were hospitalized in a period of 8 years. Median age was 63 years (range 22-86 years), mostly women (72%). Warm antibodies were detected in 36 cases (84%) and cold antibodies in seven. Seventy two percent of the patients had an underlying cause, and 58% were secondary to lymphoproliferative neoplasms. All patients except two, received steroids as initial treatment, with response in 37 (90%) of them. Three refractory patients received rituximab, with response in all of them, and relapse in one. Median follow-up was 38 months (range 2-98 months). Five year overall survival was 72%. Conclusion: AHIA in adults inpatients is a heterogeneous disease, mainly due to warm antibodies, and to secondary etiology
Disciplines: Medicina
Keyword: Hematología,
Inmunología,
Enfermedades autoinmunes,
Autoanticuerpos,
Anemia hemolítica autoinmune,
Rituximab
Keyword: Hematology,
Immunology,
Autoimmune diseases,
Autoantibodies,
Autoimmune hemolytic anemia,
Rituximab
Full text: Texto completo (Ver HTML)